Mitsubishi UFJ Capital
VC Fund
Tokyo, Japan
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
- Total investments:
- 577
- Last investment:
- Lead investor:
- 5%
- Fund size:
- $1.4B
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Mitsubishi UFJ Capital invests in
Stages Mitsubishi UFJ Capital invests in
Countries Mitsubishi UFJ Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $1.2M–$74M
- Series B
- $4.3M–$198M
Investment Focus
Industry
- Information Technology 58 (10%)
- Software 53 (9%)
- Health Care 48 (8%)
- Manufacturing 43 (7%)
- Medical 41 (7%)
Stage
- Funding Round 123 (21%)
- Series A 112 (19%)
- Series B 93 (16%)
- Seed 84 (15%)
- Series C 32 (6%)
Country
- Japan 385 (67%)
- United States 22 (4%)
- Singapore 3 (1%)
- China 1 (0%)
- Israel 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Takayuki Shimizu
Executive Officer and General Manager
|
Executive Officer and General Manager | Total investments: 6 | Find email | |
Tsuyoshi Noda
Deputy General Manager
|
Deputy General Manager | Total investments: 2 | Find email | |
|
Haruhiko Mishima
Executive Officer, General Manager
|
Executive Officer, General Manager | Total investments: 0 | Find email | |
|
Hiroaki Seki
Executive officer
|
Executive officer | Total investments: 1 | Find email | |
Junichi Taguchi
Investment Director
|
Investment Director | Total investments: 27 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
RoboTruck
|
RoboTruck develops autonomous driving technologies for huge trucks, as well as practical applications. | $31.8M / Series A / Jul 30, 2026 | |
Sinumy
|
Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology. | $3.4M / Seed / Jul 29, 2026 | |
CORE Biomedicine
|
CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology. | $21M / Series A / Jul 28, 2026 | |
PXP
|
PXP is a green tech development firm that develops clean energy using next-generation photoelectric conversion elements. | $9.6M / Series B / Jul 09, 2026 | |
Kisui Tech
|
Kisui Tech is an agricultural AI robotics company that help farmers for farming. | Venture - Series Unknown / Jul 07, 2026 | |
Neusignal Therapeutics
|
Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. | $32.8M / Series B / Jun 30, 2026 | |
|
Neusignal Therapeutics
|
Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. | $32.8M / Series B / Jun 30, 2026 | |
BETA
|
BETA is a media company that provides HRDX support business and video production services. | $6.3M / Series A / Jun 30, 2026 | |
Greenphard Energy
|
Greenphard Energy is a uniquely-placed startup in the field of intelligent IoT products based on AI and machine learning technologies. We provide SaaS solutions in the cloud for optimized control, remote monitoring, and analysis of industrial equipment, factories, and renewable energy facilities. We are also a demand response aggregator, helping tostabilize the power supply of the entire region. | $747.2K / Series A / Jun 17, 2026 | |
LIFESCAPES
|
LIFESCAPES is a research and manufacturer of brain-computer interface equipment. | $3.7M / Jun 15, 2026 | |
| See all 577 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mitsubishi UFJ Capital invest in?
Mitsubishi UFJ Capital invests primarily in Information Technology, Software and Health Care startups, most often at Funding Round and Series A stage. Most of the 577 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mitsubishi UFJ Capital's check size?
Mitsubishi UFJ Capital typically joins rounds of $1.2M–$74M at Series A and $4.3M–$198M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mitsubishi UFJ Capital participates in.
How do I contact Mitsubishi UFJ Capital?
Public channels for Mitsubishi UFJ Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mitsubishi UFJ Capital?
The team at Mitsubishi UFJ Capital includes Takayuki Shimizu (Executive Officer and General Manager), Tsuyoshi Noda (Deputy General Manager) and Haruhiko Mishima (Executive Officer, General Manager), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
